FXIII

Monoclonal antibody to human factor XIII-A (Activation Peptide, clone XTG09)



Order
Quantity
Price
Status
200 µg 365 € available


Documents
Art. No. A154
Host Mouse
Clone XTG09
Immunogen Human blood coagulation factor XIIIl-A2 (full length protein with N-terminal hexahistidin-tag) recombinantly produced in insect cells (Zedira product No. T027)
Specificity hFXIII propeptide
Appearance liquid
Description Protein G-affinity purified mouse monoclonal antibody
Formulation 0.1M PBS + 0.02% Na azide
Application Western-Blotting, ELISA;
Immunofluorescence not tested so far
Working dilutions Optimal dilutions should be determined by the end user.
E.g. for Western-Blotting or ELISA: 1 / 1,000 to 1 / 5,000 should be suitable
Storage Store at 2 – 8 °C
Delivery is possible at ambient temperature
Note INTENDED FOR RESEARCH USE ONLY, NOT FOR USE IN HUMAN, THERAPEUTIC OR DIAGNOSTIC APPLICATIONS.

Products

  • Zedira offers a huge portfolio of reliable specialist transglutaminase related products meant to catalyze research and development, both in academia and industry.

News  

  • DZG Aktuell: „Aufruf zur Teilnahme an einer weiteren Wirksamkeitsstudie mit dem Studienmedikament ZED1227“
  • imageDr. Falk Pharma and Zedira announce successful completion of the phase 2a proof-of-concept study of ZED1227 for the treatment of Celiac Disease
  • imageDr. Falk Pharma und Zedira verkünden den erfolgreichen Abschluss der Phase 2a-Studie mit ZED1227 zur Behandlung von Zöliakie
  • imageReversibly acting transglutaminase 2 inhibitors: drug candidates for the treatment of fibrosis
  • imagePress release: Zedira announces ISO 9001:2015 certification

Blog  

  • imageDesign of Oral FXIIIa Blockers as Safer Anticoagulants – Mission Impossible?
  • imageMicrobial transglutaminase (MTG) enables efficient and site-specific conjugation to native antibodies without the need of antibody engineering

Events  

  • Gordon Research Conference: Transglutaminases in Human Disease Processes

    12.06.2022 - 17.06.2022
    Mount Snow, USA

  • 19th International Celiac Disease Symposium

    19.10.2022 - 22.10.2022
    Sorrento, Italy